Clinical Trial Update: Atomoxetine and Executive Function in PTSD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating atomoxetine for executive function deficits in posttraumatic stress disorder with attention deficits; recruitment has not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Stress Disorder With Attention Defic | Phase 4 | Status: NOT_YET_RECRUITING